Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jessica Haberer, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
The acceptability and impact of a weekly text-messaging program to support HIV treatment adherence in KwaZulu-Natal, South Africa
International, 06/24/14 - 08/24/14
Assessing the social capital of caregivers for children with HIV in Mbarara, Uganda
International, 06/11/11 - 08/05/11
Factors that motivate otherwise healthy HIV+ young adults to access HIV testing and treatment in Gugulethu, South Africa: A qualitative study
Summer, 06/12/15 - 01/28/16

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K24MH114732 (HABERER, JESSICA ELIZABETH) Sep 1, 2017 - Aug 31, 2022
    NIH/NIMH
    Optimizing mHealth for adherence monitoring and intervention
    Role: Principal Investigator
  2. R01MH109309 (HABERER, JESSICA ELIZABETH) Jun 22, 2016 - Apr 30, 2020
    NIH/NIMH
    Next generation real-time monitoring for PrEP adherence in young Kenyan women
    Role: Co-Principal Investigator
  3. R21AI108329 (HABERER, JESSICA ELIZABETH) Jun 7, 2013 - May 31, 2015
    NIH/NIAID
    The ethics of electronic adherence monitoring for HIV research and care in Uganda
    Role: Co-Principal Investigator
  4. R01MH098744 (HABERER, JESSICA ELIZABETH) Jun 4, 2013 - May 31, 2018
    NIH/NIMH
    Real World Adherence to HIV PrEP in Serodiscordant African Couples
    Role: Principal Investigator
  5. R34MH100940 (HABERER, JESSICA ELIZABETH) Jun 1, 2013 - May 31, 2016
    NIH/NIMH
    Development of Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Stringer KL, Azuero A, Ott C, Psaros C, Jagielski CH, Safren SA, Haberer JE, Kempf MC. Feasibility and Acceptability of Real-Time Antiretroviral Adherence Monitoring among Depressed Women Living with HIV in the Deep South of the US. AIDS Behav. 2019 May; 23(5):1306-1314. PMID: 30377982.
    Citations:    Fields:    
  2. Ortblad KF, Kibuuka Musoke D, Ngabirano T, Nakitende A, Harling G, Haberer JE, McConnell M, Salomon JA, Oldenburg CE, Bärnighausen T. The Effect of HIV Self-Testing Delivery Models on Female Sex Workers' Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda. AIDS Behav. 2019 May; 23(5):1225-1239. PMID: 30652205.
    Citations:    Fields:    
  3. Muwonge TR, Ngure K, Katabira E, Mugo N, Kimemia G, Burns BFO, Musinguzi N, Bambia F, Baeten JM, Heffron R, Haberer JE. Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study. AIDS Behav. 2019 May; 23(5):1267-1276. PMID: 30406335.
    Citations:    Fields:    
  4. Pyra M, Anderson P, Haberer JE, Heffron R, Celum C, Asiimwe S, Katabira E, Mugo NR, Bukusi EA, Baeten JM. Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women. Front Pharmacol. 2019; 10:401. PMID: 31057407.
    Citations:    
  5. Kaida A, Kabakyenga J, Bwana M, Bajunirwe F, Muyindike W, Bennett K, Kembabazi A, Haberer JE, Boum Y, Martin JN, Hunt PW, Bangsberg DR, Matthews LT. High incidence of intended partner pregnancy among men living with HIV in rural Uganda: Implications for safer conception services. J Acquir Immune Defic Syndr. 2019 Apr 15. PMID: 30973545.
    Citations:    
  6. Dworkin MS, Panchal P, Wiebel W, Garofalo R, Haberer JE, Jimenez A. A triaged real-time alert intervention to improve antiretroviral therapy adherence among young African American men who have sex with men living with HIV: focus group findings. BMC Public Health. 2019 Apr 11; 19(1):394. PMID: 30971243.
    Citations:    
  7. Zanoni BC, Sibaya T, Cairns C, Haberer JE. Barriers to Retention in Care are Overcome by Adolescent-Friendly Services for Adolescents Living with HIV in South Africa: A Qualitative Analysis. AIDS Behav. 2019 Apr; 23(4):957-965. PMID: 30535836.
    Citations:    Fields:    
  8. Kruse G, Park ER, Shahid NN, Abroms L, Haberer JE, Rigotti NA. Combining Real-Time Ratings With Qualitative Interviews to Develop a Smoking Cessation Text Messaging Program for Primary Care Patients. JMIR Mhealth Uhealth. 2019 Mar 26; 7(3):e11498. PMID: 30912755.
    Citations:    
  9. Kruse GR, Park E, Haberer JE, Abroms L, Shahid NN, Howard SE, Chang Y, Haas JS, Rigotti NA. Proactive text messaging (GetReady2Quit) and nicotine replacement therapy to promote smoking cessation among smokers in primary care: A pilot randomized trial protocol. Contemp Clin Trials. 2019 May; 80:48-54. PMID: 30923022.
    Citations:    
  10. DeSilva M, Vu CN, Bonawitz R, Hai LT, Van Lam N, Yen LT, Gifford AL, Haberer J, Linh DT, Sabin L. The Supporting Adolescent Adherence in Vietnam (SAAV) study: study protocol for a randomized controlled trial assessing an mHealth approach to improving adherence for adolescents living with HIV in Vietnam. Trials. 2019 Feb 28; 20(1):150. PMID: 30819228.
    Citations:    
  11. Haberer JE, Bwana BM, Orrell C, Asiimwe S, Amanyire G, Musinguzi N, Siedner MJ, Matthews LT, Tsai AC, Katz IT, Bell K, Kembabazi A, Mugisha S, Kibirige V, Cross A, Kelly N, Hedt-Gauthier B, Bangsberg DR. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa. J Int AIDS Soc. 2019 Feb; 22(2):e25232. PMID: 30746898.
    Citations:    
  12. Musiimenta A, Atukunda EC, Tumuhimbise W, Haberer JE. Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda. AIDS Care. 2018 Aug; 30(sup5):S89-S96. PMID: 30626191.
    Citations:    Fields:    
  13. Haberer JE, Mugo N, Baeten JM, Pyra M, Bukusi E, Bekker LG. PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa. J Int Assoc Provid AIDS Care. 2019 Jan-Dec; 18:2325958219831011. PMID: 30776954.
    Citations:    
  14. Magidson JF, Fatch R, Orrell C, Amanyire G, Haberer JE, Hahn JA. Biomarker-Measured Unhealthy Alcohol Use in Relation to CD4 Count Among Individuals Starting ART in Sub-Saharan Africa. AIDS Behav. 2018 Dec 17. PMID: 30560484.
    Citations:    Fields:    
  15. Campbell JI, Musiimenta A, Burns B, Natukunda S, Musinguzi N, Haberer JE, Eyal N. The importance of how research participants think they are perceived: results from an electronic monitoring study of antiretroviral therapy in Uganda. AIDS Care. 2019 Jun; 31(6):761-766. PMID: 30606037.
    Citations:    Fields:    
  16. Zanoni BC, Elliott RJ, Neilan AM, Haberer JE. Screening for HIV and linkage to care in adolescents: insights from a systematic review of recent interventions in high- versus low- and middle-income settings. Adolesc Health Med Ther. 2018; 9:211-235. PMID: 30584383.
    Citations:    
  17. Meyer AJ, Babirye D, Armstrong-Hough M, Mark D, Ayakaka I, Katamba A, Haberer JE, Davis JL. Text Messages Sent to Household Tuberculosis Contacts in Kampala, Uganda: Process Evaluation. JMIR Mhealth Uhealth. 2018 Nov 20; 6(11):e10239. PMID: 30459147.
    Citations:    
  18. White EB, Meyer AJ, Ggita JM, Babirye D, Mark D, Ayakaka I, Haberer JE, Katamba A, Armstrong-Hough M, Davis JL. Feasibility, Acceptability, and Adoption of Digital Fingerprinting During Contact Investigation for Tuberculosis in Kampala, Uganda: A Parallel-Convergent Mixed-Methods Analysis. J Med Internet Res. 2018 Nov 15; 20(11):e11541. PMID: 30442637.
    Citations:    Fields:    
  19. Dunbar MS, Kripke K, Haberer J, Castor D, Dalal S, Mukoma W, Mullick S, Patel P, Reed J, Subedar H, Were D, Warren M, Torjesen K. Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa. Sex Health. 2018 Nov; 15(6):513-521. PMID: 30408431.
    Citations:    Fields:    
  20. Velloza J, Baeten JM, Haberer J, Ngure K, Irungu E, Mugo NR, Celum C, Heffron R. Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa. J Acquir Immune Defic Syndr. 2018 Nov 01; 79(3):330-338. PMID: 30063651.
    Citations:    Fields:    
  21. Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, Asiimwe S, Katabira E, Mugo NR, Baeten JM. Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships. AIDS Behav. 2018 Nov; 22(11):3718-3725. PMID: 30006791.
    Citations:    Fields:    
  22. Jarolimova J, Kabakyenga J, Bennett K, Muyindike W, Kembabazi A, Martin JN, Hunt PW, Boum Y, Haberer JE, Bangsberg DR, Kaida A, Matthews LT. Contraceptive use following unintended pregnancy among Ugandan women living with HIV. PLoS One. 2018; 13(10):e0206325. PMID: 30359430.
    Citations:    Fields:    
  23. Subbaraman R, de Mondesert L, Musiimenta A, Pai M, Mayer KH, Thomas BE, Haberer J. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Health. 2018; 3(5):e001018. PMID: 30364330.
    Citations:    
  24. Campbell JI, Eyal N, Musiimenta A, Burns B, Natukunda S, Musinguzi N, Haberer JE. Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere. AIDS Behav. 2018 Oct; 22(10):3363-3372. PMID: 29926301.
    Citations: 1     Fields:    
  25. Bell KM, Haberer JE. Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy. Curr HIV/AIDS Rep. 2018 10; 15(5):388-396. PMID: 30232578.
    Citations:    Fields:    
  26. Musinguzi N, Muwonge T, Ngure K, Katabira E, Mugo N, Burns BFO, Baeten JM, Heffron R, Haberer JE. Comparison of short messaging service self-reported adherence with other adherence measures in a demonstration project of HIV preexposure prophylaxis in Kenya and Uganda. AIDS. 2018 Sep 24; 32(15):2237-2245. PMID: 30005025.
    Citations:    Fields:    
  27. Mugwanya KK, Irungu E, Bukusi E, Mugo NR, Odoyo J, Wamoni E, Ngure K, Morton JF, Peebles K, Masyuko S, Barnabee G, Donnell D, Barnabas R, Haberer J, O'Malley G, Baeten JM. Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya. Implement Sci. 2018 09 04; 13(1):118. PMID: 30180860.
    Citations:    Fields:    Translation:HumansPHPublic Health
  28. Campbell JI, Haberer J, Musiimenta A, Eyal N. Dependence on Digital Medicine in Resource-Limited Settings. Am J Bioeth. 2018 09; 18(9):54-56. PMID: 30265607.
    Citations:    Fields:    
  29. Ortblad KF, Musoke DK, Ngabirano T, Nakitende A, Haberer JE, McConnell M, Salomon JA, Bärnighausen T, Oldenburg CE. Female Sex Workers Often Incorrectly Interpret HIV Self-Test Results in Uganda. J Acquir Immune Defic Syndr. 2018 Sep 01; 79(1):e42-e45. PMID: 29847478.
    Citations: 1     Fields:    
  30. Young CR, Kaida A, Kabakyenga J, Muyindike W, Musinguzi N, Martin JN, Hunt PW, Bangsberg DR, Haberer JE, Matthews LT. Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda. PLoS One. 2018; 13(8):e0202992. PMID: 30148854.
    Citations:    Fields:    
  31. Pyra M, Anderson PL, Hendrix CW, Heffron R, Mugwanya K, Haberer JE, Thomas KK, Celum C, Donnell D, Marzinke MA, Bukusi EA, Mugo NR, Asiimwe S, Katabira E, Baeten JM. Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis. AIDS. 2018 Aug 24; 32(13):1891-1898. PMID: 29894385.
    Citations:    Fields:    
  32. Boum Ii Y, Burns BF, Siedner M, Mburu Y, Bukusi E, Haberer JE. Advancing equitable global health research partnerships in Africa. BMJ Glob Health. 2018; 3(4):e000868. PMID: 30167335.
    Citations:    
  33. Chang JL, Lee SA, Tsai AC, Musinguzi N, Muzoora C, Bwana B, Boum Y, Haberer JE, Hunt PW, Martin J, Bangsberg DR, Kroetz DL, Siedner MJ. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. AIDS Res Hum Retroviruses. 2018 Nov; 34(11):982-992. PMID: 29973058.
    Citations:    Fields:    
  34. Muiru AN, Bibangambah P, Hemphill L, Sentongo R, Kim JH, Triant VA, Bangsberg DR, Tsai AC, Martin JN, Haberer JE, Boum Y, Plutzky J, Hunt PW, Okello S, Siedner MJ. Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda. J Acquir Immune Defic Syndr. 2018 Aug 01; 78(4):458-464. PMID: 29652762.
    Citations:    Fields:    
  35. McCluskey SM, Lee GQ, Kamelian K, Kembabazi A, Musinguzi N, Bwana MB, Muzoora C, Haberer JE, Hunt PW, Martin JN, Boum Y, Bangsberg DR, Harrigan PR, Siedner MJ. Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013. AIDS Patient Care STDS. 2018 Jul; 32(7):257-264. PMID: 29985647.
    Citations:    Fields:    
  36. Chang JL, Tsai AC, Musinguzi N, Haberer JE, Boum Y, Muzoora C, Bwana M, Martin JN, Hunt PW, Bangsberg DR, Siedner MJ. Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study. Ann Intern Med. 2018 Aug 07; 169(3):146-155. PMID: 29946683.
    Citations:    Fields:    
  37. Heffron R, Thomson K, Celum C, Haberer J, Ngure K, Mugo N, Bukusi E, Katabira E, Odoyo J, Bulya N, Asiimwe S, Tindimwebwa E, Baeten JM. Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples. AIDS Behav. 2018 Jun; 22(6):1758-1765. PMID: 28894986.
    Citations: 1     Fields:    
  38. Musiimenta A, Atukunda EC, Tumuhimbise W, Pisarski EE, Tam M, Wyatt MA, Ware NC, Haberer JE. Acceptability and Feasibility of Real-Time Antiretroviral Therapy Adherence Interventions in Rural Uganda: Mixed-Method Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 May 17; 6(5):e122. PMID: 29773527.
    Citations:    
  39. Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. Int J Tuberc Lung Dis. 2018 05 01; 22(5):530-536. PMID: 29663958.
    Citations:    Fields:    
  40. Castillo-Mancilla JR, Morrow M, Boum Y, Byakwaga H, Haberer JE, Martin JN, Bangsberg D, Mawhinney S, Musinguzi N, Huang Y, Tracy RP, Burdo TH, Williams K, Muzzora C, Hunt PW, Siedner MJ. Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. J Acquir Immune Defic Syndr. 2018 04 15; 77(5):507-513. PMID: 29346185.
    Citations:    Fields:    
  41. Mugyenyi AEK, Haberer JE, O'Neil I. Pleasure and practice: a qualitative study of the individual and social underpinnings of shisha use in cafes among youth in the UK. BMJ Open. 2018 04 13; 8(4):e018989. PMID: 29654007.
    Citations:    Fields:    
  42. Armstrong-Hough M, Ggita J, Ayakaka I, Dowdy D, Cattamanchi A, Haberer JE, Katamba A, Davis JL. Brief Report: "Give Me Some Time": Facilitators of and Barriers to Uptake of Home-Based HIV Testing During Household Contact Investigation for Tuberculosis in Kampala, Uganda. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):400-404. PMID: 29300218.
    Citations:    Fields:    
  43. Abaasa A, Hendrix C, Gandhi M, Anderson P, Kamali A, Kibengo F, Sanders EJ, Mutua G, Bumpus NN, Priddy F, Haberer JE. Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value. AIDS Behav. 2018 04; 22(4):1165-1173. PMID: 29090394.
    Citations: 1     Fields:    
  44. Harris RA, Haberer JE, Musinguzi N, Chang KM, Schechter CB, Doubeni CA, Gross R. Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model. PLoS One. 2018; 13(3):e0194713. PMID: 29566096.
    Citations:    Fields:    Translation:HumansCells
  45. Lambert RF, Orrell C, Bangsberg DR, Haberer JE. Factors that Motivated Otherwise Healthy HIV-Positive Young Adults to Access HIV Testing and Treatment in South Africa. AIDS Behav. 2018 03; 22(3):733-741. PMID: 28190116.
    Citations: 1     Fields:    
  46. Cabral A, M Baeten J, Ngure K, Velloza J, Odoyo J, E Haberer J, Celum C, Muwonge T, Asiimwe S, Heffron R. Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda. J Acquir Immune Defic Syndr. 2018 02 01; 77(2):154-159. PMID: 29076883.
    Citations:    Fields:    Translation:HumansPHPublic Health
  47. Castillo-Mancilla JR, Haberer JE. Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring. Curr HIV/AIDS Rep. 2018 02; 15(1):49-59. PMID: 29380227.
    Citations: 1     Fields:    
  48. Pyra M, Haberer JE, Heffron R, Kidoguchi L, Brown ER, Bukusi EA, Asiimwe S, Celum C, Katabira E, Mugo NR, Baeten JM. Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships. J Acquir Immune Defic Syndr. 2018 01 01; 77(1):41-45. PMID: 29016523.
    Citations:    Fields:    Translation:HumansPHPublic Health
  49. Zanoni BC, Sibaya T, Cairns C, Lammert S, Haberer JE. Higher retention and viral suppression with adolescent-focused HIV clinic in South Africa. PLoS One. 2017; 12(12):e0190260. PMID: 29287088.
    Citations: 1     Fields:    Translation:Humans
  50. Lambert RF, Orrell C, Haberer JE. "It was pain. That's it. It was pain." Lack of oral health care among otherwise healthy young adults living with HIV in South Africa: A qualitative study. PLoS One. 2017; 12(12):e0188353. PMID: 29272290.
    Citations:    Fields:    Translation:Humans
  51. Haberer JE, Ngure K, Muwonge T, Mugo N, Katabira E, Heffron R, Musinguzi N, Bangsberg DR, Celum C, Baeten JM. Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa. J Acquir Immune Defic Syndr. 2017 12 15; 76(5):488-492. PMID: 28961676.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  52. Ortblad K, Kibuuka Musoke D, Ngabirano T, Nakitende A, Magoola J, Kayiira P, Taasi G, Barresi LG, Haberer JE, McConnell MA, Oldenburg CE, Bärnighausen T. Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial. PLoS Med. 2017 Nov; 14(11):e1002458. PMID: 29182634.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  53. Lee GQ, Bangsberg DR, Mo T, Lachowski C, Brumme CJ, Zhang W, Lima VD, Boum Y, Mwebesa BB, Muzoora C, Andia I, Mbalibulha Y, Kembabazi A, Carroll R, Siedner MJ, Haberer JE, Mocello AR, Kigozi SH, Hunt PW, Martin JN, Harrigan PR. Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches. AIDS. 2017 11 13; 31(17):2345-2354. PMID: 28832407.
    Citations:    Fields:    Translation:HumansCells
  54. Armstrong-Hough M, Turimumahoro P, Meyer AJ, Ochom E, Babirye D, Ayakaka I, Mark D, Ggita J, Cattamanchi A, Dowdy D, Mugabe F, Fair E, Haberer JE, Katamba A, Davis JL. Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study. PLoS One. 2017; 12(11):e0187145. PMID: 29108007.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  55. Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, Kidoguchi L, Donnell D, Mugo NR, Bukusi EA, Katabira E, Asiimwe S, Morton J, Morrison S, Haugen H, Mujugira A, Haberer JE, Ware NC, Wyatt MA, Marzinke MA, Frenkel LM, Celum C, Baeten JM. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Res. 2017 Nov 06; 1:3. PMID: 29355231.
    Citations: 1     
  56. Campbell JI, Aturinda I, Mwesigwa E, Burns B, Santorino D, Haberer JE, Bangsberg DR, Holden RJ, Ware NC, Siedner MJ. The Technology Acceptance Model for Resource-Limited Settings (TAM-RLS): A Novel Framework for Mobile Health Interventions Targeted to Low-Literacy End-Users in Resource-Limited Settings. AIDS Behav. 2017 Nov; 21(11):3129-3140. PMID: 28421356.
    Citations: 3     Fields:    Translation:Humans
  57. Linnemayr S, Huang H, Luoto J, Kambugu A, Thirumurthy H, Haberer JE, Wagner G, Mukasa B. Text Messaging for Improving Antiretroviral Therapy Adherence: No Effects After 1 Year in a Randomized Controlled Trial Among Adolescents and Young Adults. Am J Public Health. 2017 12; 107(12):1944-1950. PMID: 29048966.
    Citations: 5     Fields:    Translation:Humans
  58. Lee GQ, McCluskey S, Boum Y, Hunt PW, Martin JN, Bangsberg DR, Gao X, Harrigan PR, Haberer JE, Siedner MJ. Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa? J Acquir Immune Defic Syndr. 2017 10 01; 76(2):188-192. PMID: 28639996.
    Citations:    Fields:    Translation:HumansCells
  59. McCluskey SM, Boum Y, Musinguzi N, Haberer JE, Martin JN, Hunt PW, Marconi VC, Bangsberg DR, Siedner MJ. Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr. 2017 10 01; 76(2):183-187. PMID: 28628529.
    Citations:    Fields:    Translation:HumansCells
  60. Richardson HS, Eyal N, Campbell JI, Haberer JE. When Ancillary Care Clashes with Study Aims. N Engl J Med. 2017 Sep 28; 377(13):1213-1215. PMID: 28953445.
    Citations: 1     Fields:    Translation:Humans
  61. Mujugira A, Baeten J, Kidoguchi L, Haberer J, Celum C, Donnell D, Ngure K, Bukusi E, Mugo N, Asiimwe S, Odoyo J, Tindimwebwa E, Bulya N, Katabira E, Heffron R. High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy. AIDS Res Hum Retroviruses. 2018 02; 34(2):140-147. PMID: 28899162.
    Citations:    Fields:    
  62. Matthews LT, Burns BF, Bajunirwe F, Kabakyenga J, Bwana M, Ng C, Kastner J, Kembabazi A, Sanyu N, Kusasira A, Haberer JE, Bangsberg DR, Kaida A. Beyond HIV-serodiscordance: Partnership communication dynamics that affect engagement in safer conception care. PLoS One. 2017; 12(9):e0183131. PMID: 28880892.
    Citations:    Fields:    Translation:HumansPHPublic Health
  63. Garrison LE, Haberer JE. Technological methods to measure adherence to antiretroviral therapy and preexposure prophylaxis. Curr Opin HIV AIDS. 2017 Sep; 12(5):467-474. PMID: 28590335.
    Citations:    Fields:    Translation:HumansPHPublic Health
  64. Velloza J, Celum C, Haberer JE, Ngure K, Irungu E, Mugo N, Baeten JM, Heffron R. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda. AIDS Behav. 2017 Aug; 21(8):2509-2518. PMID: 28634661.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  65. Andriesen J, Bull S, Dietrich J, Haberer JE, Van Der Pol B, Voronin Y, Wall KM, Whalen C, Priddy F. Using Digital Technologies in Clinical HIV Research: Real-World Applications and Considerations for Future Work. J Med Internet Res. 2017 07 31; 19(7):e274. PMID: 28760729.
    Citations: 1     Fields:    Translation:Humans
  66. Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. J Int AIDS Soc. 2017 07 25; 20(1):21842. PMID: 28741331.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  67. Mugyenyi GR, Atukunda EC, Ngonzi J, Boatin A, Wylie BJ, Haberer JE. Functionality and acceptability of a wireless fetal heart rate monitoring device in term pregnant women in rural Southwestern Uganda. BMC Pregnancy Childbirth. 2017 Jun 08; 17(1):178. PMID: 28595604.
    Citations:    Fields:    Translation:Humans
  68. Thomson KA, Haberer JE, Marzinke MA, Mujugira A, Hendrix CW, Celum C, Ndase P, Ronald A, Bangsberg DR, Baeten JM. Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):184-189. PMID: 28291050.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  69. Musinguzi N, Mocello RA, Boum Y, Hunt PW, Martin JN, Haberer JE, Bangsberg DR, Siedner MJ. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda. AIDS Behav. 2017 Jun; 21(6):1735-1740. PMID: 27256394.
    Citations: 5     Fields:    Translation:Humans
  70. North CM, Valeri L, Hunt PW, Mocello AR, Martin JN, Boum Y, Haberer JE, Bangsberg DR, Christiani DC, Siedner MJ. Cooking fuel and respiratory symptoms among people living with HIV in rural Uganda. ERJ Open Res. 2017 Apr; 3(2). PMID: 28534032.
    Citations: 1     
  71. Mayer KH, Safren SA, Elsesser SA, Psaros C, Tinsley JP, Marzinke M, Clarke W, Hendrix C, Wade Taylor S, Haberer J, Mimiaga MJ. Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP". AIDS Behav. 2017 May; 21(5):1350-1360. PMID: 27848089.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  72. Lee S, Byakwaga H, Boum Y, Burdo TH, Williams KC, Lederman MM, Huang Y, Tracy RP, Cao H, Haberer JE, Kembabazi A, Bangsberg DR, Martin JN, Hunt PW. Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. J Infect Dis. 2017 04 15; 215(8):1270-1274. PMID: 28329310.
    Citations: 1     Fields:    Translation:HumansCells
  73. Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, Vreeman RC, Wilson I, Sam-Agudu NA, Blaschke TF, Vrijens B, Mellins CA, Remien RH, Weiser SD, Lowenthal E, Stirratt MJ, Sow PS, Thomas B, Ford N, Mills E, Lester R, Nachega JB, Bwana BM, Ssewamala F, Mbuagbaw L, Munderi P, Geng E, Bangsberg DR. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017 Mar 22; 20(1):1-15. PMID: 28364569.
    Citations:    
  74. Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, Vreeman RC, Wilson I, Sam-Agudu NA, Blaschke TF, Vrijens B, Mellins CA, Remien RH, Weiser SD, Lowenthal E, Stirratt MJ, Sow PS, Thomas B, Ford N, Mills E, Lester R, Nachega JB, Bwana BM, Ssewamala F, Mbuagbaw L, Munderi P, Geng E, Bangsberg DR. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017; 20(1):21371. PMID: 28630651.
    Citations: 11     Fields:    Translation:Humans
  75. Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implement Sci. 2017 03 09; 12(1):33. PMID: 28274245.
    Citations: 6     Fields:    Translation:Humans
  76. Georgette N, Siedner MJ, Petty CR, Zanoni BC, Carpenter S, Haberer JE. Impact of a clinical program using weekly Short Message Service (SMS) on antiretroviral therapy adherence support in South Africa: a retrospective cohort study. BMC Med Inform Decis Mak. 2017 Feb 20; 17(1):18. PMID: 28219372.
    Citations: 4     Fields:    Translation:Humans
  77. Atukunda EC, Musiimenta A, Musinguzi N, Wyatt MA, Ashaba J, Ware NC, Haberer JE. Understanding Patterns of Social Support and Their Relationship to an ART Adherence Intervention Among Adults in Rural Southwestern Uganda. AIDS Behav. 2017 Feb; 21(2):428-440. PMID: 27671479.
    Citations: 3     Fields:    Translation:Humans
  78. Haberer JE, Musinguzi N, Tsai AC, Boum Y, Bwana BM, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring. AIDS. 2017 01 02; 31(1):169-171. PMID: 27835622.
    Citations: 9     Fields:    Translation:Humans
  79. Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. J Acquir Immune Defic Syndr. 2017 01 01; 74 Suppl 1:S15-S22. PMID: 27930607.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  80. Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. J Acquir Immune Defic Syndr. 2017 Jan 01; 74 Suppl 6:S15-S22. PMID: 27923009.
    Citations:    
  81. Madrasi K, Chaturvedula A, Haberer JE, Sale M, Fossler MJ, Bangsberg D, Baeten JM, Celum C, Hendrix CW. Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis. J Clin Pharmacol. 2017 05; 57(5):606-615. PMID: 27922719.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  82. Okello S, Asiimwe SB, Kanyesigye M, Muyindike WR, Boum Y, Mwebesa BB, Haberer JE, Huang Y, Williams K, Burdo TH, Tracy RP, Bangsberg DR, Mocello AR, Martin JN, Hunt PW, Siedner MJ. D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. J Acquir Immune Defic Syndr. 2016 Dec 01; 73(4):396-402. PMID: 27171743.
    Citations: 2     Fields:    Translation:Humans
  83. Haberer JE. Actionable adherence monitoring to optimise intervention. Lancet HIV. 2017 01; 4(1):e5-e6. PMID: 27864001.
    Citations: 3     Fields:    Translation:Humans
  84. Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, Tappero JW, Kiarie J, Ronald A, Mujugira A, Tumwesigye E, Were E, Irungu E, Baeten JM. Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study. J Acquir Immune Defic Syndr. 2016 11 01; 73(3):313-322. PMID: 27243900.
    Citations: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  85. Georgette N, Siedner MJ, Zanoni B, Sibaya T, Petty CR, Carpenter S, Haberer JE. The Acceptability and Perceived Usefulness of a Weekly Clinical SMS Program to Promote HIV Antiretroviral Medication Adherence in KwaZulu-Natal, South Africa. AIDS Behav. 2016 11; 20(11):2629-2638. PMID: 26781866.
    Citations: 3     Fields:    Translation:Humans
  86. Musinguzi N, Muwonge T, Thomas K, Baeten JM, Bangsberg DR, Haberer JE. Does Adherence Change When No One is Looking? Comparing Announced and Unannounced Tenofovir Levels in a PrEP Trial. AIDS Behav. 2016 11; 20(11):2639-2643. PMID: 26781865.
    Citations: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  87. Zanoni BC, Archary M, Buchan S, Katz IT, Haberer JE. Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave. BMJ Glob Health. 2016; 1(3):e000004. PMID: 28588949.
    Citations: 6     
  88. Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, Asiimwe S, Haberer JE, Morton J, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Hendrix C, Marzinke MA, Ware NC, Wyatt MA, Morrison S, Haugen H, Mujugira A, Donnell D, Celum C. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda. PLoS Med. 2016 08; 13(8):e1002099. PMID: 27552090.
    Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
  89. Lu Y, Goti V, Chaturvedula A, Haberer JE, Fossler MJ, Sale ME, Bangsberg D, Baeten JM, Celum CL, Hendrix CW. Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods. Antimicrob Agents Chemother. 2016 09; 60(9):5379-86. PMID: 27353269.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  90. Haberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, Bangsberg DR. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016 05 15; 30(8):1295-300. PMID: 26760452.
    Citations: 17     Fields:    Translation:Humans
  91. Ware NC, Pisarski EE, Tam M, Wyatt MA, Atukunda E, Musiimenta A, Bangsberg DR, Haberer JE. The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016 05 15; 30(8):1287-94. PMID: 26807967.
    Citations: 14     Fields:    Translation:Humans
  92. Boatin AA, Wylie BJ, Goldfarb I, Azevedo R, Pittel E, Ng C, Haberer JE. Wireless Vital Sign Monitoring in Pregnant Women: A Functionality and Acceptability Study. Telemed J E Health. 2016 07; 22(7):564-71. PMID: 27172448.
    Citations: 5     Fields:    Translation:Humans
  93. Musinguzi N, Muganzi CD, Boum Y, Ronald A, Marzinke MA, Hendrix CW, Celum C, Baeten JM, Bangsberg DR, Haberer JE. Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa. AIDS. 2016 Apr 24; 30(7):1121-9. PMID: 26785125.
    Citations: 4     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  94. Matthews LT, Ribaudo HB, Kaida A, Bennett K, Musinguzi N, Siedner MJ, Kabakyenga J, Hunt PW, Martin JN, Boum Y, Haberer JE, Bangsberg DR. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. J Acquir Immune Defic Syndr. 2016 Apr 01; 71(4):399-406. PMID: 26495883.
    Citations: 12     Fields:    Translation:HumansCells
  95. Siedner MJ, Kim JH, Nakku RS, Hemphill L, Triant VA, Haberer JE, Martin JN, Boum Y, Kwon DS, Tsai AC, Hunt PW, Okello S, Bangsberg DR. HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS. 2016 Feb 20; 30(4):667-70. PMID: 26636926.
    Citations: 5     Fields:    Translation:Humans
  96. Haberer JE. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Curr Opin HIV AIDS. 2016 Jan; 11(1):10-7. PMID: 26633638.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  97. Haberer JE, Musinguzi N, Boum Y, Siedner MJ, Mocello AR, Hunt PW, Martin JN, Bangsberg DR. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):386-92. PMID: 26110445.
    Citations: 18     Fields:    Translation:Humans
  98. Campbell JI, Haberer JE. Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances. Curr HIV/AIDS Rep. 2015 Dec; 12(4):523-31. PMID: 26439917.
    Citations: 2     Fields:    Translation:Humans
  99. Campbell JI, Eyal N, Musiimenta A, Haberer JE. Ethical Questions in Medical Electronic Adherence Monitoring. J Gen Intern Med. 2016 Mar; 31(3):338-42. PMID: 26358284.
    Citations: 11     Fields:    Translation:Humans
  100. Siedner MJ, Kim JH, Nakku RS, Bibangambah P, Hemphill L, Triant VA, Haberer JE, Martin JN, Mocello AR, Boum Y, Kwon DS, Tracy RP, Burdo T, Huang Y, Cao H, Okello S, Bangsberg DR, Hunt PW. Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. J Infect Dis. 2016 Feb 01; 213(3):370-8. PMID: 26347573.
    Citations: 20     Fields:    Translation:Humans
  101. Sabin LL, Bachman DeSilva M, Gill CJ, Zhong L, Vian T, Xie W, Cheng F, Xu K, Lan G, Haberer JE, Bangsberg DR, Li Y, Lu H, Gifford AL. Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology Study. J Acquir Immune Defic Syndr. 2015 Aug 15; 69(5):551-9. PMID: 25886927.
    Citations: 32     Fields:    Translation:Humans
  102. Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, Anderson P, Mugo N, Venter F, Goicochea P, Caceres C, O'Reilly K. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015 Jul 17; 29(11):1277-85. PMID: 26103095.
    Citations: 32     Fields:    Translation:HumansPHPublic Health
  103. Siedner MJ, Santorino D, Lankowski AJ, Kanyesigye M, Bwana MB, Haberer JE, Bangsberg DR. A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study. BMC Med. 2015 Jul 06; 13:160. PMID: 26149722.
    Citations:    
  104. Nieves CI, Kaida A, Seage GR, Kabakyenga J, Muyindike W, Boum Y, Mocello AR, Martin JN, Hunt PW, Haberer JE, Bangsberg DR, Matthews LT. The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. Contraception. 2015 Aug; 92(2):152-9. PMID: 25983013.
    Citations: 5     Fields:    Translation:Humans
  105. Petersen ML, LeDell E, Schwab J, Sarovar V, Gross R, Reynolds N, Haberer JE, Goggin K, Golin C, Arnsten J, Rosen MI, Remien RH, Etoori D, Wilson IB, Simoni JM, Erlen JA, van der Laan MJ, Liu H, Bangsberg DR. Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):109-18. PMID: 25942462.
    Citations: 6     Fields:    Translation:Humans
  106. Ware NC, Pisarski EE, Haberer JE, Wyatt MA, Tumwesigye E, Baeten JM, Celum CL, Bangsberg DR. Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study. AIDS Behav. 2015 May; 19(5):811-20. PMID: 25267114.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  107. Kintu A, Hankinson SE, Balasubramanian R, Ertel K, Tumwesigye E, Bangsberg DR, Haberer JE. Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):36-43. PMID: 25942457.
    Citations:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  108. Mugo PM, Sanders EJ, Mutua G, van der Elst E, Anzala O, Barin B, Bangsberg DR, Priddy FH, Haberer JE. Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya. AIDS Behav. 2015 May; 19(5):794-801. PMID: 25432877.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  109. Kreitchmann R, Coelho DF, Kakehasi FM, Hofer CB, Read JS, Losso M, Haberer JE, Siberry GK, Harris DR, Yu Q. Long-term postpartum adherence to antiretroviral drugs among women in Latin America. Int J STD AIDS. 2016 Apr; 27(5):377-86. PMID: 25931238.
    Citations:    Fields:    Translation:Humans
  110. Rana Y, Haberer J, Huang H, Kambugu A, Mukasa B, Thirumurthy H, Wabukala P, Wagner GJ, Linnemayr S. Short message service (SMS)-based intervention to improve treatment adherence among HIV-positive youth in Uganda: focus group findings. PLoS One. 2015; 10(4):e0125187. PMID: 25881059.
    Citations: 10     Fields:    Translation:HumansCells
  111. Olds PK, Kiwanuka JP, Ware NC, Tsai AC, Haberer JE. Explaining antiretroviral therapy adherence success among HIV-infected children in rural Uganda: a qualitative study. AIDS Behav. 2015 Apr; 19(4):584-93. PMID: 25323679.
    Citations: 3     Fields:    Translation:Humans
  112. Siedner MJ, Santorino D, Haberer JE, Bangsberg DR. Know your audience: predictors of success for a patient-centered texting app to augment linkage to HIV care in rural Uganda. J Med Internet Res. 2015 Mar 24; 17(3):e78. PMID: 25831269.
    Citations: 12     Fields:    Translation:Humans
  113. Boatin AA, Wylie B, Goldfarb I, Azevedo R, Pittel E, Ng C, Haberer J. Wireless fetal heart rate monitoring in inpatient full-term pregnant women: testing functionality and acceptability. PLoS One. 2015; 10(1):e0117043. PMID: 25622043.
    Citations: 1     Fields:    Translation:Humans
  114. Chan BT, Weiser SD, Boum Y, Siedner MJ, Mocello AR, Haberer JE, Hunt PW, Martin JN, Mayer KH, Bangsberg DR, Tsai AC. Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS. 2015 Jan 02; 29(1):83-90. PMID: 25268886.
    Citations: 15     Fields:    Translation:Humans
  115. Chan BT, Weiser SD, Boum Y, Haberer JE, Kembabazi A, Hunt PW, Martin JN, Mocello AR, Bangsberg DR, Tsai AC. Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav. 2015 Jan; 19(1):19-26. PMID: 24788780.
    Citations: 4     Fields:    Translation:Humans
  116. Baxi SM, Liu A, Bacchetti P, Mutua G, Sanders EJ, Kibengo FM, Haberer JE, Rooney J, Hendrix CW, Anderson PL, Huang Y, Priddy F, Gandhi M. Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr. 2015 Jan 01; 68(1):13-20. PMID: 25296098.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  117. Psaros C, Haberer JE, Boum Y, Tsai AC, Martin JN, Hunt PW, Bangsberg DR, Safren SA. The factor structure and presentation of depression among HIV-positive adults in Uganda. AIDS Behav. 2015 Jan; 19(1):27-33. PMID: 24854877.
    Citations: 8     Fields:    Translation:Humans
  118. Olds PK, Kiwanuka JP, Nansera D, Huang Y, Bacchetti P, Jin C, Gandhi M, Haberer JE. Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda. AIDS Care. 2015; 27(3):327-32. PMID: 25483955.
    Citations: 8     Fields:    Translation:Humans
  119. Bajunirwe F, Haberer JE, Boum Y, Hunt P, Mocello R, Martin JN, Bangsberg DR, Hahn JA. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. PLoS One. 2014; 9(12):e113152. PMID: 25436894.
    Citations: 19     Fields:    Translation:Humans
  120. Kaida A, Matthews LT, Ashaba S, Tsai AC, Kanters S, Robak M, Psaros C, Kabakyenga J, Boum Y, Haberer JE, Martin JN, Hunt PW, Bangsberg DR. Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2014 Dec 01; 67 Suppl 4:S179-87. PMID: 25436816.
    Citations: 10     Fields:    Translation:Humans
  121. Atwiine B, Kiwanuka J, Musinguzi N, Atwine D, Haberer JE. Understanding the role of age in HIV disclosure rates and patterns for HIV-infected children in southwestern Uganda. AIDS Care. 2015; 27(4):424-30. PMID: 25397994.
    Citations: 8     Fields:    Translation:Humans
  122. Baeten JM, Donnell D, Mugo NR, Ndase P, Thomas KK, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kidoguchi L, Coombs RW, Hendrix C, Marzinke MA, Frenkel L, Haberer JE, Bangsberg D, Celum C. Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2014 Nov; 14(11):1055-1064. PMID: 25300863.
    Citations: 26     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  123. Heffron R, Celum C, Mugo N, Katabira E, Bukusi E, Asiimwe S, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Donnell D, Haberer JE, Kidoguchi L, Morton J, Baeten JM. High Initiation and Adherence among High Risk African HIV Discordant Couples in a Demonstration Project of PrEP and ART for HIV Prevention. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A71-2. PMID: 25357925.
    Citations:    
  124. Mayer KH, Safren S, Haberer J, Elsesser S, Clarke W, Hendrix CW, Marzinke M, Mimiaga MJ. Project PrEPARE: High Levels of Medication Adherence with Continued Condomless Sex in U.S. Men who Have Sex with Men in an Oral PrEP Adherence Trial. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A23-4. PMID: 25357645.
    Citations:    
  125. Chan BT, Weiser SD, Boum Y, Siedner MJ, Mocello AR, Haberer JE, Hunt PW, Martin JN, Mayer KH, Bangsberg DR, Tsai AC. Persistent HIV-related Stigma in Rural Uganda during a Period of Increasing HIV Incidence. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A259. PMID: 25357728.
    Citations:    
  126. Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, Baeten JM, Celum C, Bangsberg DR, Safren SA. An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):522-9. PMID: 24853311.
    Citations: 16     Fields:    Translation:Humans
  127. Lankowski AJ, Tsai AC, Kanyesigye M, Bwana M, Haberer JE, Wenger M, Martin JN, Bangsberg DR, Hunt PW, Siedner MJ. Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3036. PMID: 25101890.
    Citations:    Fields:    Translation:Humans
  128. Takada S, Weiser SD, Kumbakumba E, Muzoora C, Martin JN, Hunt PW, Haberer JE, Kawuma A, Bangsberg DR, Tsai AC. The dynamic relationship between social support and HIV-related stigma in rural Uganda. Ann Behav Med. 2014 Aug; 48(1):26-37. PMID: 24500077.
    Citations: 19     Fields:    Translation:Humans
  129. McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, Pouget ER, Trabold N, Haberer JE. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges. AIDS Patient Care STDS. 2014 Sep; 28(9):462-74. PMID: 25045996.
    Citations: 21     Fields:    Translation:HumansPHPublic Health
  130. Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C, Celum C. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014 Jul 01; 66(3):340-8. PMID: 24784763.
    Citations: 73     Fields:    Translation:HumansCTClinical Trials
  131. Kruse GR, Bangsberg DR, Hahn JA, Haberer JE, Hunt PW, Muzoora C, Bennett JP, Martin JN, Rigotti NA. Tobacco use among adults initiating treatment for HIV infection in rural Uganda. AIDS Behav. 2014 Jul; 18(7):1381-9. PMID: 24638166.
    Citations: 2     Fields:    Translation:Humans
  132. Venkataramani AS, Thirumurthy H, Haberer JE, Ii YB, Siedner MJ, Kembabazi A, Hunt PW, Martin JN, Bangsberg DR, Tsai AC. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS. 2014 May 15; 28(8):1221-6. PMID: 24406678.
    Citations: 8     Fields:    Translation:Humans
  133. Machtinger EL, Lavin SM, Hilliard S, Jones R, Haberer JE, Capito K, Dawson-Rose C. An expressive therapy group disclosure intervention for women living with HIV improves social support, self-efficacy, and the safety and quality of relationships: a qualitative analysis. J Assoc Nurses AIDS Care. 2015 Mar-Apr; 26(2):187-98. PMID: 25027284.
    Citations: 3     Fields:    Translation:Humans
  134. Martinez P, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Huang Y, Haberer JE, Martin JN, Bangsberg DR, Hunt PW. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr. 2014 Apr 01; 65(4):456-62. PMID: 24220289.
    Citations: 28     Fields:    Translation:Humans
  135. Kiwanuka J, Mulogo E, Haberer JE. Caregiver perceptions and motivation for disclosing or concealing the diagnosis of HIV infection to children receiving HIV care in Mbarara, Uganda: a qualitative study. PLoS One. 2014; 9(3):e93276. PMID: 24667407.
    Citations: 14     Fields:    Translation:Humans
  136. Byakwaga H, Boum Y, Huang Y, Muzoora C, Kembabazi A, Weiser SD, Bennett J, Cao H, Haberer JE, Deeks SG, Bangsberg DR, McCune JM, Martin JN, Hunt PW. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. J Infect Dis. 2014 Aug 01; 210(3):383-91. PMID: 24585899.
    Citations: 35     Fields:    Translation:HumansCells
  137. Siedner MJ, Musinguzi N, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Bennett J, Hunt PW, Martin JN, Haberer JE, Bangsberg DR. Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS. 2014 Jan 14; 28(2):267-71. PMID: 24361683.
    Citations: 6     Fields:    Translation:Humans
  138. Tsai AC, Bangsberg DR, Kegeles SM, Katz IT, Haberer JE, Muzoora C, Kumbakumba E, Hunt PW, Martin JN, Weiser SD. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013 Dec; 46(3):285-94. PMID: 23690283.
    Citations: 46     Fields:    Translation:Humans
  139. Tsai AC, Bangsberg DR, Bwana M, Haberer JE, Frongillo EA, Muzoora C, Kumbakumba E, Hunt PW, Martin JN, Weiser SD. How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda. AIDS Behav. 2013 Oct; 17(8):2725-31. PMID: 23670710.
    Citations: 25     Fields:    Translation:Humans
  140. Matthews LT, Kaida A, Kanters S, Byakwagamd H, Mocello AR, Muzoora C, Kembabazi A, Haberer JE, Martin JN, Bangsberg DR, Hunt PW. HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods. AIDS. 2013 Oct; 27 Suppl 1:S105-12. PMID: 24088676.
    Citations: 10     Fields:    Translation:HumansCells
  141. Kibengo FM, Ruzagira E, Katende D, Bwanika AN, Bahemuka U, Haberer JE, Bangsberg DR, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Kamali A, Priddy FH. Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. PLoS One. 2013; 8(9):e74314. PMID: 24086333.
    Citations: 24     Fields:    Translation:Humans
  142. Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, Bangsberg DR. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med. 2013; 10(9):e1001511. PMID: 24058300.
    Citations: 60     Fields:    Translation:Humans
  143. Haberer JE, Kiwanuka J, Nansera D, Muzoora C, Hunt PW, So J, O'Donnell M, Siedner M, Martin JN, Bangsberg DR. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS. 2013 Aug 24; 27(13):2166-8. PMID: 23751260.
    Citations: 25     Fields:    Translation:HumansCells
  144. Kembabazi A, Bajunirwe F, Hunt PW, Martin JN, Muzoora C, Haberer JE, Bangsberg DR, Siedner MJ. Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda. PLoS One. 2013; 8(7):e69634. PMID: 23894514.
    Citations: 7     Fields:    Translation:Humans
  145. Bachman Desilva M, Gifford AL, Keyi X, Li Z, Feng C, Brooks M, Harrold M, Yueying H, Gill CJ, Wubin X, Vian T, Haberer J, Bangsberg D, Sabin L. Feasibility and Acceptability of a Real-Time Adherence Device among HIV-Positive IDU Patients in China. AIDS Res Treat. 2013; 2013:957862. PMID: 23956851.
    Citations: 16     
  146. Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr. 2013 Jul; 63 Suppl 2:S122-9. PMID: 23764623.
    Citations: 54     Fields:    Translation:Humans
  147. Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013 Jul; 17(6):2162-72. PMID: 23080358.
    Citations: 50     Fields:    Translation:HumansCTClinical Trials
  148. Kaida A, Matthews LT, Kanters S, Kabakyenga J, Muzoora C, Mocello AR, Martin JN, Hunt P, Haberer J, Hogg RS, Bangsberg DR. Correction: Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda. PLoS One. 2013; 8(6). PMID: 29161730.
    Citations:    Fields:    
  149. Siedner MJ, Lankowski A, Tsai AC, Muzoora C, Martin JN, Hunt PW, Haberer JE, Bangsberg DR. GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS. 2013 Jun 01; 27(9):1503-8. PMID: 23435294.
    Citations: 40     Fields:    Translation:Humans
  150. Chaiyachati KH, Loveday M, Lorenz S, Lesh N, Larkan LM, Cinti S, Friedland GH, Haberer JE. A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program. PLoS One. 2013; 8(5):e64662. PMID: 23724075.
    Citations: 20     Fields:    Translation:Humans
  151. Kaida A, Matthews LT, Kanters S, Kabakyenga J, Muzoora C, Mocello AR, Martin JN, Hunt P, Haberer J, Hogg RS, Bangsberg DR. Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda. PLoS One. 2013; 8(5):e63411. PMID: 23704906.
    Citations: 20     Fields:    Translation:Humans
  152. Hofer CB, Harris DR, Saavedra MC, Haberer JE, Romeiro J, Mussi-Pinhata MM, Stankievich E, Gomes IM, Kreitchmann R, Read JS. Adherence to antiretroviral prophylaxis during early infancy in Latin America. Braz J Infect Dis. 2013 Jul-Aug; 17(4):495-6. PMID: 23680065.
    Citations:    Fields:    Translation:Humans
  153. Haberer JE, Trabin T, Klinkman M. Furthering the reliable and valid measurement of mental health screening, diagnoses, treatment and outcomes through health information technology. Gen Hosp Psychiatry. 2013 Jul-Aug; 35(4):349-53. PMID: 23628162.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  154. Baylor A, Muzoora C, Bwana M, Kembabazi A, Haberer JE, Matthews LT, Tsai AC, Hunt PW, Martin JN, Bangsberg DR. Dissemination of research findings to research participants living with HIV in rural Uganda: challenges and rewards. PLoS Med. 2013; 10(3):e1001397. PMID: 23472055.
    Citations: 4     Fields:    Translation:Humans
  155. Adakun SA, Siedner MJ, Muzoora C, Haberer JE, Tsai AC, Hunt PW, Martin JN, Bangsberg DR. Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):317-21. PMID: 23242160.
    Citations: 22     Fields:    Translation:Humans
  156. Bangsberg DR, Haberer JE. Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence". JAMA Intern Med. 2013 Feb 25; 173(4):306-7. PMID: 23358810.
    Citations: 3     Fields:    Translation:HumansCells
  157. Horwitz RH, Tsai AC, Maling S, Bajunirwe F, Haberer JE, Emenyonu N, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda. AIDS Behav. 2013 Jan; 17(1):260-5. PMID: 22246516.
    Citations: 4     Fields:    Translation:Humans
  158. Machtinger EL, Haberer JE, Wilson TC, Weiss DS. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav. 2012 Nov; 16(8):2160-70. PMID: 22426597.
    Citations: 17     Fields:    Translation:Humans
  159. Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012 Nov; 16(8):2091-100. PMID: 22249954.
    Citations: 58     Fields:    Translation:Humans
  160. Siedner MJ, Lankowski A, Musinga D, Jackson J, Muzoora C, Hunt PW, Martin JN, Bangsberg DR, Haberer JE. Optimizing network connectivity for mobile health technologies in sub-Saharan Africa. PLoS One. 2012; 7(9):e45643. PMID: 23029155.
    Citations: 9     Fields:    Translation:Humans
  161. Bärnighausen T, Chaiyachati K, Chimbindi N, Haberer J, Newell ML. Antiretroviral therapy requires life-long adherence - Authors' reply. Lancet Infect Dis. 2012 Sep; 12(9):662. PMID: 22917100.
    Citations:    
  162. Siedner MJ, Tsai AC, Dworkin S, Mukiibi NF, Emenyonu NI, Hunt PW, Haberer JE, Martin JN, Bangsberg DR, Weiser SD. Sexual relationship power and malnutrition among HIV-positive women in rural Uganda. AIDS Behav. 2012 Aug; 16(6):1542-8. PMID: 22382629.
    Citations: 5     Fields:    Translation:Humans
  163. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 02; 367(5):399-410. PMID: 22784037.
    Citations: 797     Fields:    Translation:HumansCellsCTClinical Trials
  164. Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, Muzoora C, Geng E, Martin JN, Bangsberg DR. Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012; 7(6):e39894. PMID: 22761924.
    Citations: 24     Fields:    Translation:Humans
  165. Siedner MJ, Haberer JE, Bwana MB, Ware NC, Bangsberg DR. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak. 2012 Jun 21; 12:56. PMID: 22720901.
    Citations: 24     Fields:    Translation:Humans
  166. Kreitchmann R, Harris DR, Kakehasi F, Haberer JE, Cahn P, Losso M, Teles E, Pilotto JH, Hofer CB, Read JS. Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDS. 2012 Aug; 26(8):486-95. PMID: 22663185.
    Citations: 16     Fields:    Translation:Humans
  167. Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS One. 2012; 7(5):e36737. PMID: 22590600.
    Citations: 24     Fields:    Translation:HumansCellsCTClinical Trials
  168. van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS. 2012 Apr 24; 26(7):F13-9. PMID: 22333749.
    Citations: 138     Fields:    Translation:HumansCells
  169. Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. J Acquir Immune Defic Syndr. 2012 Apr 15; 59(5):463-8. PMID: 22267018.
    Citations: 99     Fields:    Translation:HumansCTClinical Trials
  170. Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Priddy FH. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS One. 2012; 7(4):e33103. PMID: 22511916.
    Citations: 52     Fields:    Translation:HumansCells
  171. Haberer JE, Robbins GK, Ybarra M, Monk A, Ragland K, Weiser SD, Johnson MO, Bangsberg DR. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012 Feb; 16(2):375-82. PMID: 21448728.
    Citations: 26     Fields:    Translation:Humans
  172. Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011 Dec; 11(12):942-51. PMID: 22030332.
    Citations: 85     Fields:    Translation:Humans
  173. Haberer JE, Cook A, Walker AS, Ngambi M, Ferrier A, Mulenga V, Kityo C, Thomason M, Kabamba D, Chintu C, Gibb DM, Bangsberg DR. Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One. 2011 Apr 21; 6(4):e18505. PMID: 21533031.
    Citations: 40     Fields:    Translation:Humans
  174. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, MacKeen L, Haberer J, Kimaiyo S, Sidle J, Ngare D, Bangsberg DR. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011 Mar 27; 25(6):825-34. PMID: 21252632.
    Citations: 284     Fields:    Translation:Humans
  175. Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010 Dec; 14(6):1294-301. PMID: 20532605.
    Citations: 47     Fields:    Translation:Humans
  176. Haberer JE, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, Bangsberg DR. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010 Dec; 14(6):1340-6. PMID: 20809380.
    Citations: 72     Fields:    Translation:Humans
  177. Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, Bangsberg DR. Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health. 2010 Sep; 7(3):279-86. PMID: 20719215.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  178. Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2009 Nov; 6(4):194-200. PMID: 19849962.
    Citations: 55     Fields:    Translation:Humans
  179. Zhang F, Haberer J, Wei H, Wang N, Chu A, Zhao Y, Zhao H. Drug resistance in the Chinese National Pediatric Highly Active Antiretroviral Therapy Cohort: implications for paediatric treatment in the developing world. Int J STD AIDS. 2009 Jun; 20(6):406-9. PMID: 19451326.
    Citations: 3     Fields:    Translation:HumansCells
  180. Zhang F, Haberer JE, Zhao Y, Dou Z, Zhao H, He Y, Cao GH. Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes. J Acquir Immune Defic Syndr. 2007 Dec 15; 46(5):594-8. PMID: 18043313.
    Citations: 12     Fields:    Translation:Humans
  181. Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, Yu L, Goosby EP. The Chinese free antiretroviral treatment program: challenges and responses. AIDS. 2007 Dec; 21 Suppl 8:S143-8. PMID: 18172383.
    Citations: 69     Fields:    Translation:HumansPHPublic Health
  182. Zhang F, Au MC, Bouey PD, Zhao Y, Huang ZJ, Dou Z, Li Z, Haberer J, Chen RY, Yu L. The diagnosis and treatment of HIV-infected children in China: challenges and opportunities. J Acquir Immune Defic Syndr. 2007 Apr 01; 44(4):429-34. PMID: 17224849.
    Citations: 7     Fields:    Translation:Humans
  183. Zhang FJ, Maria A, Haberer J, Zhao Y. Overview of HIV drug resistance and its implications for China. Chin Med J (Engl). 2006 Dec 05; 119(23):1999-2004. PMID: 17199945.
    Citations: 4     Fields:    Translation:HumansCells
  184. Haberer JE, Garrett B, Baker LC. Does Medicaid managed care affect access to care for the uninsured? Health Aff (Millwood). 2005 Jul-Aug; 24(4):1095-105. PMID: 16012150.
    Citations: 2     Fields:    Translation:Humans
  185. Matthew R, Banjevic M, Chan AS, Myers L, Wolkowicz R, Haberer J, Singer J. Use of the l1 norm for selection of sparse parameter sets that accurately predict drug response phenotype from viral genetic sequences. AMIA Annu Symp Proc. 2005; 505-9. PMID: 16779091.
    Citations:    Fields:    Translation:HumansCells
  186. Haberer J, Trivedi NN, Kohlwes J, Tierney L. Clinical problem-solving. A gut feeling. N Engl J Med. 2003 Jul 03; 349(1):73-8. PMID: 12840095.
    Citations: 2     Fields:    Translation:Humans
  187. Haberer JE, Ix JH, Tierney LM. Clinical problem-solving. One foot away. N Engl J Med. 2002 May 02; 346(18):1394-7. PMID: 11986414.
    Citations: 1     Fields:    Translation:HumansCells
  188. Haberer JE, Da-Cruz AM, Soong L, Oliveira-Neto MP, Rivas L, McMahon-Pratt D, Coutinho SG. Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis. Infect Immun. 1998 Jul; 66(7):3100-5. PMID: 9632572.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  189. Martinez P, Haberer JP, Hannhart B, Saunier C, Laxenaire MC. [Comparative evaluation of 13 pulse oximeters]. Ann Fr Anesth Reanim. 1989; 8 Suppl:R225. PMID: 2604184.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Haberer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (358)
Explore
_
Co-Authors (46)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.